Nifty
Sensex
:
:
13817.55
46874.36
-149.95 (-1.07%)
-535.57 (-1.13%)

Pharmaceuticals & Drugs

Rating :
83/99  (View)

BSE: 524752 | NSE: Not Listed

36.40
-0.60 (-1.62%)
28-Jan-2021 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  38.70
  •  38.70
  •  35.20
  •  37.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4436
  •  1.61
  •  40.60
  •  17.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 37.37
  • 25.28
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 47.01
  • N/A
  • 2.93

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 45.94%
  • 5.19%
  • 27.93%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 20.94%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 45.20
  • 186.51

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 104.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 82.83

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 38.42
  • 44.35

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.62
  • 3.31
  • 4.15

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.39
  • 25.28
  • 31.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
13.51
1.23
998.37%
14.22
1.44
887.50%
17.59
1.22
1,341.80%
3.72
0.64
481.25%
Expenses
12.63
0.88
1,335.23%
13.52
1.33
916.54%
16.16
1.07
1,410.28%
3.15
0.52
505.77%
EBITDA
0.88
0.36
144.44%
0.70
0.11
536.36%
1.44
0.15
860.00%
0.57
0.13
338.46%
EBIDTM
6.54%
28.86%
4.92%
7.55%
8.16%
11.99%
15.29%
19.44%
Other Income
0.10
0.01
900.00%
0.18
0.00
0.00
0.25
0.00
0.00
0.01
0.00
0.00
Interest
0.33
0.13
153.85%
0.38
0.00
0.00
0.48
0.00
0.00
0.12
0.00
0.00
Depreciation
0.20
0.22
-9.09%
0.20
0.00
0.00
0.20
0.00
0.00
0.14
0.00
0.00
PBT
0.45
0.02
2,150.00%
0.30
0.11
172.73%
1.01
0.15
573.33%
0.33
0.13
153.85%
Tax
0.14
-0.03
-
0.09
0.03
200.00%
0.31
0.03
933.33%
0.07
0.00
0.00
PAT
0.31
0.05
520.00%
0.20
0.08
150.00%
0.70
0.11
536.36%
0.26
0.13
100.00%
PATM
2.29%
4.07%
1.43%
5.68%
4.00%
9.11%
6.96%
19.44%
EPS
0.31
0.06
416.67%
0.20
0.10
100.00%
0.70
0.14
400.00%
0.26
0.16
62.50%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Net Sales
49.04
23.99
8.06
1.02
Net Sales Growth
982.56%
197.64%
690.20%
 
Cost Of Goods Sold
0.12
0.62
5.92
0.39
Gross Profit
48.92
23.37
2.14
0.62
GP Margin
99.75%
97.42%
26.55%
60.78%
Total Expenditure
45.46
21.46
7.61
0.95
Power & Fuel Cost
-
0.07
0.02
0.00
% Of Sales
-
0.29%
0.25%
0%
Employee Cost
-
19.55
1.09
0.15
% Of Sales
-
81.49%
13.52%
14.71%
Manufacturing Exp.
-
0.01
0.00
0.01
% Of Sales
-
0.04%
0%
0.98%
General & Admin Exp.
-
1.08
0.48
0.29
% Of Sales
-
4.50%
5.96%
28.43%
Selling & Distn. Exp.
-
0.01
0.01
0.01
% Of Sales
-
0.04%
0.12%
0.98%
Miscellaneous Exp.
-
0.13
0.08
0.09
% Of Sales
-
0.54%
0.99%
8.82%
EBITDA
3.59
2.53
0.45
0.07
EBITDA Margin
7.32%
10.55%
5.58%
6.86%
Other Income
0.54
0.27
0.00
0.11
Interest
1.31
0.77
0.01
0.00
Depreciation
0.74
0.56
0.00
0.00
PBT
2.09
1.47
0.44
0.18
Tax
0.61
0.37
0.04
0.00
Tax Rate
29.19%
25.17%
9.09%
0.00%
PAT
1.47
1.10
0.41
0.18
PAT before Minority Interest
1.47
1.10
0.41
0.18
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
3.00%
4.59%
5.09%
17.65%
PAT Growth
297.30%
168.29%
127.78%
 
Unadjusted EPS
1.46
1.09
0.41
0.18

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Shareholder's Funds
12.56
2.53
2.12
Share Capital
10.10
8.00
8.00
Total Reserves
2.46
-5.47
-5.88
Non-Current Liabilities
1.43
0.00
0.00
Secured Loans
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Current Liabilities
23.02
3.82
0.84
Trade Payables
7.20
3.13
0.56
Other Current Liabilities
4.30
0.45
0.15
Short Term Borrowings
11.11
0.20
0.13
Short Term Provisions
0.41
0.04
0.00
Total Liabilities
37.01
6.35
2.96
Net Block
4.98
0.01
0.00
Gross Block
4.99
0.01
0.00
Accumulated Depreciation
0.01
0.00
0.00
Non Current Assets
12.66
0.03
0.00
Capital Work in Progress
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
Long Term Loans & Adv.
0.07
0.02
0.00
Other Non Current Assets
7.61
0.00
0.00
Current Assets
24.35
6.32
2.96
Current Investments
0.00
0.00
0.00
Inventories
0.32
0.32
0.10
Sundry Debtors
14.62
3.46
0.59
Cash & Bank
1.47
0.30
0.02
Other Current Assets
7.95
0.03
0.02
Short Term Loans & Adv.
2.30
2.21
2.23
Net Current Assets
1.33
2.50
2.12
Total Assets
37.01
6.35
2.96

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
-15.18
0.23
-0.10
PBT
1.47
0.44
0.18
Adjustment
1.77
0.00
0.00
Changes in Working Capital
-18.42
-0.21
-0.28
Cash after chg. in Working capital
-15.18
0.23
-0.10
Interest Paid
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-0.12
-0.02
0.00
Net Fixed Assets
-0.10
-0.01
Net Investments
-8.36
-0.05
Others
8.34
0.04
Cash from Financing Activity
18.03
0.07
0.09
Net Cash Inflow / Outflow
2.73
0.28
-0.01
Opening Cash & Equivalents
0.30
0.02
0.03
Closing Cash & Equivalent
3.14
0.30
0.02

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
12.44
3.16
2.65
ROA
5.08%
8.71%
6.16%
ROE
14.59%
17.45%
8.60%
ROCE
16.97%
17.95%
8.10%
Fixed Asset Turnover
9.59
1060.24
0.00
Receivable days
137.52
91.60
211.11
Inventory Days
4.87
9.49
34.94
Payable days
90.40
92.70
291.89
Cash Conversion Cycle
51.99
8.39
-45.83
Total Debt/Equity
0.88
0.08
0.06
Interest Cover
2.90
72.10
0.00

Annual Reports:


News Update


  • Decipher Labs gets approval for incorporation of subsidiary company
    1st Jan 2021, 12:28 PM

    The approval is for incorporation of a subsidiary company for dealing with pharmaceuticals

    Read More
  • Decipher Labs considering business expansion of portfolio to cater to retail sales of medicines
    24th Dec 2020, 12:24 PM

    The Board proposes to create a separate subsidiary company to market various formulations and other allied products

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.